| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |